08.25.25 -- Services Designed To Take You From Molecule To Market

Accelerate your biopharma journey with a comprehensive service portfolio designed to speed development, reduce costs, and minimize risk from molecule to market.

One Team, One Roof, One CDMO

ReciBioPharm’s expanded biologics services and technologies encompass the entire RNA development and manufacturing value chain, helping to deliver your innovation to patients seamlessly.

Elevate your nucleic acid analysis with these high-quality consumables and analysis kits that are designed to enhance the accuracy and efficiency of nucleic acid analysis, from genomic DNA and RNA analysis to quality control of NGS.

Unlock automated, precise biomolecular structure measurements from a single drop. Gain cleaner, faster, more critical insights into your biomolecules with this innovative solution.

Primer Support™ 5G solid support is the fifth-generation solid support for oligonucleotide synthesis from Cytiva. By using Cytiva consumables, you can better leverage the whole family knowledge and expertise to efficiently optimize your molecule’s development.

Achieve uniformity and control in nanoparticle synthesis with an advanced system that streamlines production, reduces human intervention, and delivers exceptional particle characteristics for diverse applications.

By combining disruptive technology platforms with unparalleled genomic medicine development expertise, we're positioned to accelerate the development of LNP formulations and drug products.

Configurable FlexFactory™ biomanufacturing process trains can help scientists better control the production and processing of different viral vectors and new modalities—all within the same space. Plan your agile manufacturing strategy with greater efficiency and integration to address capacity needs.

Explore the evolving landscape of early-phase oncology clinical trials, including strategic insights to empower operations teams in optimizing study design, site selection, and recruitment.

Ensure the safety and efficacy of your mRNA therapeutics with high-quality, GMP-grade reagents from a trusted partner with a multi-tiered quality approach to deliver manufacturing certainty.

Find out how revolutionary and environmentally sustainable nanoparticle technologies coupled with innovative formulation approaches can address drug solubility issues and add value for patients.

Watch to explore how you can speed up your mRNA-based drug projects, reduce risks, and shorten time to market with comprehensive and seamless processes from pre-clinical development to commercialization.

Explore new approach methodologies, integrating in vitro and computational models to improve toxicology testing, and drug development, enhancing accuracy, efficiency, and human relevance.

Discover enhanced pharmaceutical manufacturing with automated HPLC for peptide and small molecule purification, featuring robust controls, high-performance capabilities, and compliance with regulatory standards.

Unlock the full potential of your pDNA purification with advanced chromatography solutions and resins that tackle high viscosity and impurities to ensure superior quality and yield.

Delve into the world of lipid nanoparticle (LNP) production and formulation, exploring cutting-edge technologies and applications in targeted drug delivery.

With our scale and experience in both chemistry and biologics, Curia is uniquely positioned to provide mRNA drug development solutions.

Review our full range of support services to streamline manufacturing processes through to the commercialization of aseptic and lyophilized products.

As OGNT-based therapeutics continue to gain traction in drug development, precise identification and quantification are essential for ensuring their efficacy and safety.